Fewer Major Amputations Among Individuals With Diabetes in Finland in 1997–2007: A population-based study by Ikonen, Tuija S. et al.
Fewer Major Amputations Among
Individuals With Diabetes in Finland in
1997–2007
A population-based study
TUIJA S. IKONEN, MD, PHD
1
REIJO SUND, DSOCSC
1 MAARIT VENERMO, MD, PHD
2
KLAS WINELL, MD
1
OBJECTIVE — Complications occur in diabetes despite rigorous efforts to control risk fac-
tors. Since 2000, the National Development Programme for the Prevention and Care of Diabetes
hasworkedtohalvetheincidenceofamputationsin10years.Hereweevaluatetheimpactofthe
efforts undertaken by analyzing the major amputations done in 1997–2007.
RESEARCH DESIGN AND METHODS — All individuals with diabetes (n  396,317)
wereidentiﬁedfromcomprehensivenationaldatabases.Dataontheﬁrstmajoramputations(n
9,481) performed for diabetic and nondiabetic individuals were obtained from the National
Hospital Discharge Register.
RESULTS — Therelativeriskfortheﬁrstmajoramputationwas7.4(95%CI7.2–7.7)among
the diabetic versus the nondiabetic population. The standardized incidence of the ﬁrst major
amputationdecreasedamongthediabeticandnondiabeticpopulations(48.8and25.2%relative
risk reduction, respectively) over 11 years, and the time from the registration of diabetes to the
ﬁrst major amputation was signiﬁcantly longer, on average 1.2 years more. The cumulative
ﬁve-year postamputation mortality among diabetic individuals was 78.7%.
CONCLUSIONS — In our nationwide diabetes database, the duration from the registration
of diabetes to the ﬁrst major amputation increased, and the incidence of major amputations
decreased almost 50% in 11 years. Approximately half of this change was due to the increasing
sizeofthediabeticpopulation.Theriskformajoramputationismorethansevenfoldthatamong
the nondiabetic population. These results pose a continuous challenge to improve diabetes care.
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D
iabetes is increasing rapidly in Fin-
land (1). For this reason, the Na-
tional Development Programme
for the Prevention and Care of Diabetes
(DEHKO) was established for the years
2000–2010(2).Theprogramhasspeciﬁc
goalsthataimtoreducethecomplications
of diabetes; one of them is to halve the
incidence of lower limb amputations.
The majority of amputations are per-
formed for diabetic individuals. In Ger-
many, 66% of lower limb amputations
were performed for patients with diabe-
tes; the relative risk was 8.8 for men and
5.7forwomencomparedwiththatforthe
nondiabetic population (3). The inci-
dence of lower limb amputations among
diabetic populations has varied from 2.1
to 13.7 per 1,000 person-years (4). In
Suffolk, U.K., the incidence of major am-
putations was as low as 1.62 (5), and, in
Sweden, the incidence of the ﬁrst above-
transmetatarsal-level amputation was
1.92 for women and 1.97 for men with
diabetes (6). The amputation risk was
eightfold (6).
Falling amputation trends are de-
scribed.Amongtype1diabeticpatientsin
Sweden, the relative risk of lower limb
amputation was 0.6 during the most re-
cent 5-year period compared against the
5-year period before the year 2000 (7). In
Scotland, the incidence of major amputa-
tions decreased from 5.1 to 2.9 per 1,000
patients with diabetes in 7 years (8). In
Suffolk, U.K., major amputations de-
creased 82% from 1995 to 2005 (9).
A great deal of the improvement in
amputation trends is attributed to diabe-
tes control programs. In the U.K., a
control program led to a drop in the am-
putation incidence from 5.6 to 1.76 (10).
In South Carolina, an education program
brought about a decrease in lower limb
amputations that was faster than that in
other parts of the U.S. (11). Vascular sur-
gery has an impact: in Denmark, a seven-
fold increase in vascular surgical activity
was associated with a 75% decrease in
major amputations from 1981 to 1995
(12).
It is still unclear whether the impact
of programs is related to earlier diagnosis
of diabetes or reﬂects a true effect of im-
proved care. Multidisciplinary teamwork
focusing on foot care and a continuous
prospective audit has been shown to be
beneﬁcial (9). A thorough analysis of
comprehensive register data may widen
theperspectivegivenbyﬁguresonampu-
tation incidence among the diabetic
population.
The aim of our study was to analyze
the ﬁrst major amputations among dia-
betic individuals identiﬁed from compre-
hensive national databases during 1997–
2007 and to evaluate the impact of efforts
to improve diabetes care in Finland.
Trendsinamputationrates,timefromthe
registration of diabetes to the ﬁrst major
amputation, and mortality were com-
pared by sex and age-groups within and
between diabetic and nondiabetic
populations.
RESEARCH DESIGN AND
METHODS— The total diabetic pop-
ulationinFinlandduring1997–2007was
obtained from the FinDM II database,
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identiﬁed from 1) the register of individ-
uals eligible for elevated reimbursement
of medication for chronic conditions in-
cluding diabetes (years 1964–2007), 2)
the prescription register including all re-
imbursed medicines purchased (years
1994–2007), 3) the national hospital dis-
chargeregistersincluding3a)allinpatient
care (years 1969–2007) and 3b) outpa-
tienthospitalvisits(years1998–2007),4)
the causes-of-death register (1971–
2007), and 5) the medical birth register
(1987–2007). Finnish personal identity
codes allowed deterministic record
linkage.
Individuals were considered to have
diabetes since the ﬁrst registration of dia-
betes in any of these registers. Women
with gestational diabetes mellitus only
were excluded. Individuals with diabetes
were divided into subgroups depending
on the hypoglycemic medication they
used. Individuals with prescription data
on insulin purchases for each possible
yearandnopurchasesformedicationthat
stimulates insulin secretion (sulfonyl-
ureas, sitagliptin, vildagliptin, repaglin-
ide, nateglinide, or exenatide) were
considered to have insulin-treated diabe-
tes (ITDM). The others were deﬁned as
having non–insulin-treated diabetes
(NITDM). The data included 50,027 in-
dividuals with ITDM and 346,290 indi-
viduals with NITDM. individuals with
ITDM were divided into two groups
based on age at the ﬁrst registration of
diabetes: the Y-ITDM group included in-
dividuals aged 40 years (n  33,805)
and the O-ITDM group included individ-
uals aged 40 years (n  16,222) at reg-
istration. The Y-ITDM group contained
individuals with type 1 diabetes, the
NITDM group included individuals with
type 2 diabetes, and the O-ITDM group
was a mixed group consisting of individ-
uals with late-onset type 1 diabetes and
individuals with type 2 diabetes treated
with insulin.
The incidence of the ﬁrst major am-
putation among patients with diabetes
was compared with the incidence among
nondiabetic individuals in Finland (total
population 5 million). Data obtained
from the hospital discharge register for
amputations were identiﬁed using proce-
dure codes (the classiﬁcation of the Finn-
ish Hospital League for 1987–1996
[9573, 9574, and 9575] and the Nordic
Classiﬁcation on Surgical Procedures
since 1996 [NFQ10, NFQ20, NGQ10,
NGQ20, and NHQ10]) (13,14). Record
linkage between the diabetes register and
the amputation with an encrypted per-
sonal identity code was used to identify
the ﬁrst major amputation for each per-
son. The follow-up started in 1987. In re-
porting the ﬁrst major amputation in
1997–2007, as a rule for the ﬁrst major
amputation, a 10-year major amputation
free period was used; only 0.8% of major
amputations were detected beyond this
time range. Amputations performed be-
fore the year of the ﬁrst diabetes registra-
tion were considered as not being
diabetes-related.
Age- and sex-adjusted incidences
were calculated by using indirect stan-
dardization. For the nondiabetic group,
follow-up times were calculated by sub-
tracting the number of the prevalent
population with diabetes from the
corresponding population ﬁgures in Fin-
land. Age-adjusted relative risks between
the groups were derived by means of in-
direct standardization. Mean ages at am-
putation were compared between the
groups using parametric t tests and non-
parametric Mann-Whitney tests. The av-
erage duration from the registration of
diabetestotheﬁrstmajoramputationwas
adjusted for age at diabetes registration
and compared among groups with a re-
gression model. Cumulative mortalities
were calculated using the product limit
estimator and compared using log-rank
tests. The analyses were performed with
the Survo MM (http://www.survo.ﬁ) and
SAS 9.1.3 (http://www.sas.com) software
packages.
RESULTS— A total of 9,481 ﬁrst ma-
jor amputations were performed in Fin-
land during 1997–2007. Of these, 5,047
(53.2%) were performed on individuals
with diabetes, 973 (10.3%) were per-
formed on individuals with ITDM (474
[5.0%] for individuals in the Y-ITDM
group and 499 [5.3%] for individuals in
the O-ITDM group), and 4,074 (43.0%)
forindividualswithNITDM.Ofamputees
without diabetes, 204 were found to de-
velop diabetes later. Below-knee amputa-
tions were more common among
individuals with diabetes than among in-
dividuals without it (supplementary Ta-
ble 1A, available in an online appendix
at http://care.diabetesjournals.org/cgi/
content/full/dc10-0462).
Over 11 years, the standardized inci-
dence of the ﬁrst major amputation de-
creasedsigniﬁcantlyinallgroups(Fig.1).
The decrease among all diabetic individ-
uals was from 94.4 per 100,000 in year
1997 to 48.3 per 100,000 in year 2007,
corresponding to 48.8% relative risk re-
duction. Among individuals without dia-
betes, the risk for major amputation
decreased from 10.7 to 8.0 per 100,000,
with a relative risk reduction of 25.2%.
Figure 1—Standardized incidence (log scale) of the ﬁrst major amputation per 100,000 person-
years among individuals with diabetes in Finland 1997–2007. Non-DM, individuals without
diabetes.
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reductioninamputationincidencewould
have been among individuals with diabe-
tesfrom1997to2007ifthediabeticpop-
ulation had changed in the same way as
the general population. In that case, the
relative risk reduction among individuals
with diabetes dropped from 48.8% to
28.8%, i.e., at the same level as the rela-
tiveriskreductionamongthenondiabetic
population.
Forthewholeobservationperiod,the
standardized incidence of the ﬁrst major
amputation among the diabetic popula-
tionwasonaverage7.4-fold(95%CI7.2–
7.7) compared with that for the
nondiabetic population. The relative risk
was 8.9 (8.6–9.3) for men and 6.3 (6.1–
6.6) for women. It was greatest among
those aged 30–49 years, being 44.3
(37.2–52.5) for men and 68.8 (54.0–
86.4) for women. From 1997–2000 to
2004–2007, the relative risk among indi-
viduals with diabetes decreased signiﬁ-
cantly, especially among those aged 65
years compared with individuals without
diabetes (Table 1).
The mean age at the time of the ﬁrst
major amputation was lower among men
than among women (69.8 vs. 78.6 years;
P  0.0001): in the O-ITDM group, 69.9
vs. 76.0 years (P  0.0001); in the
NITDM group, 71.9 vs. 79.1 years (P 
0.0001);andamongthosewithoutdiabe-
tes, 70.2 vs. 80.1 years (P  0.0001), re-
spectively.OnlyintheY-ITDMgroupwas
the mean age signiﬁcantly higher among
men than among women (54.3 vs. 51.8
years, P  0.005). The mean age at am-
putation was lower among all diabetic in-
dividuals compared with nondiabetic
individuals (73.2 vs. 75.5 years; P 
0.0001); the difference was greater
among women than among men (2.9 vs.
0.7 years). No statistical differences were
found for any groups between 1997–
2000 and 2004–2007 (Table 2).
After adjustment for age at registra-
tion, the time from the registration of di-
abetes to the ﬁrst major amputation
increased 1.2 years (P  0.0001) from
1997–2000 to 2004–2007. In the Y-
ITDM group the change was 3.2 years
(P0.0001),intheO-ITDMgroupitwas
0.9 year (P  0.12), and among individ-
uals with NITDM it was 1.1 years (P 
0.0001).ThechangesintheITDMgroups
were greater among women than among
men (Table 2).
Five-year cumulative mortality from
all causes after the ﬁrst major amputation
among the diabetic population is pre-
sented in Fig. 2. The 5-year mortality was
highest among men aged 74 years
(89.7%) and lowest among men aged
65 years (59.5%) (Fig. 2A). Unlike that
in older groups, mortality in the youngest
age-groupwassigniﬁcantlyhigheramong
women than among men (P  0.04). In-
Table1—Relativeriskoftheﬁrstmajoramputationamongindividualswithdiabetes(menand
womenseparatelybyage-groups)vs.nondiabeticindividualsduringtheﬁrst(1997–2000)and
last (2004–2007) 4 years of the observation period
Relative risk (95% CI)
1997–2000 2004–2007
Men by age-groups
30–49 years 55.5 (42.1–71.9) 35.9 (26.1–48.2)
50–64 years 22.9 (19.9–26.2) 16.2 (14.2–18.3)
65–74 years 13.5 (12.1–15.0) 7.4 (6.5–8.3)
75 years 7.3 (6.6–8.2) 4.5 (4.0–5.0)
All 11.7 (10.9–12.4) 7.0 (6.5–7.4)
Women by age-groups
30–49 years 81.1 (54.7–115.8) 55.0 (34.9–82.5)
50–64 years 29.3 (22.9–37.1) 19.8 (15.5–25.0)
65–74 years 18.1 (15.9–20.6) 7.1 (5.8–8.5)
75 years 6.9 (6.4–7.4) 3.7 (3.4–4.0)
All 8.8 (8.3–9.3) 4.5 (4.2–4.8)
Table2—Meanageatamputationfortheﬁrstmajoramputationandintervalfromdiabetesregistrationtotheﬁrstmajoramputation,adjusted
for registration age, among men and women in the Y-ITDM, O-ITDM, and NITDM groups and nondiabetic individuals during the ﬁrst
(1997–2000) and last (2004–2007) 4 years of the observation period
1997–2000 2004–2007
Difference (P
value)*
No.
amputees
Age at ﬁrst major
amputation
(years)
Interval from diabetes
registration to ﬁrst
major amputation
(years)
No.
amputees
Age at ﬁrst major
amputation
(years)
Interval from diabetes
registration to ﬁrst
major amputation
(years)
Men
Y-ITDM 122 54.1 (52.4–55.9) 28.8 (27.6–30.1) 115 54.4 (52.5–56.4) 31.5 (30.1–32.8) 2.6 (0.003)
O-ITDM 119 70.4 (68.8–72.0) 16.7 (15.2–18.1) 67 68.7 (66.2–71.2) 17.2 (15.2–19.1) 0.5 (0.34)
NITDM 703 72.0 (71.2–72.7) 11.6 (11.1–12.0) 751 71.9 (71.2–72.6) 12.8 (12.4–13.3) 1.3 (0.0001)
All diabetic 944 69.5 (68.7–70.2) 14.4 (14.0–14.8) 933 69.5 (68.7–70.3) 15.5 (15.0–15.9) 1.1 (0.0002)
Nondiabetic 844 70.3 (69.3–71.4) 650 70.4 (69.1–71.7)
Women
Y-ITDM 62 50.7 (48.1–53.2) 28.8 (27.0–30.6) 44 52.5 (49.3–55.7) 33.4 (31.3–35.5) 4.6 (0.0006)
O-ITDM 100 75.0 (73.7–76.4) 18.7 (17.4–20.0) 67 77.2 (75.2–79.2) 20.7 (19.1–22.3) 2.0 (0.03)
NITDM 888 79.1 (78.5–79.6) 11.7 (11.3–12.1) 625 79.7 (79.0–80.5) 12.7 (12.2–13.2) 1.0 (0.0004)
All diabetic 1,050 77.0 (76.4–77.7) 13.4 (13.0–13.8) 736 77.9 (77.0–78.7) 14.6 (14.2–15.1) 1.3 (0.0001)
Nondiabetic 923 80.1 (79.3–80.9) 840 80.7 (79.9–81.5)
Data are means (95% CI) unless otherwise indicated. *P value for the difference in interval between periods, adjusted for registration age (years).
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5-yearcumulativemortality(65.4%)than
individuals in other groups (Fig. 2B).
Mortalitywaslowerafterbelow-kneever-
sus above-knee amputation (72.1% vs.
86.7%) (Fig. 2C).
CONCLUSIONS — In our nation-
wide study, the standardized incidence of
the ﬁrst major amputation among dia-
betic population has decreased almost
50% from 1997 to 2007. The time from
the registration of diabetes to the ﬁrst ma-
jor amputation increased by 0.5 to 4.6
years, depending on the diabetic group
andsex,from1997–2000to2004–2007.
Thisincrease,especiallyamongyoungin-
dividuals with insulin-treated diabetes, is
clinically relevant. The prolonged ampu-
tation-free interval, decreasing amputa-
tion incidence, and the falling total
number of amputations between these
two chronological cohorts suggest that
substantial progress promoting limb sal-
vage has taken place. To our knowledge,
this is the ﬁrst report at a national level to
provide a combined outcome of these in-
dicators in an unselected population with
diabetes in which the information on di-
abetes and major amputations has been
linked for individuals.
Two concerns should be mentioned.
Despitetheincreaseddurationofdiabetes
before amputation, the age at amputation
remained unaltered. This result may be
related to a tendency for diabetes to be
acquired or diagnosed at an earlier age,
especially in individuals with type 2 dia-
betes. Because the Y-ITDM group com-
prised young insulin-treated individuals,
earlier diagnosis is hardly an explanation
forthem.Furthermore,becausethenum-
ber of individuals with diabetes in Fin-
land has increased by 65% from 1997 to
2007 (1), there may be some dilution of
the incidence owing to more effective de-
tection of diabetes. When the risk reduc-
tion was calculated against the total
population, the amputation incidence
among individuals with diabetes fell in a
waysimilartothatamongnondiabeticin-
dividuals, by 28.8 and 25.2% in 11 years.
At least this amount of incidence reduc-
tion can be attributed to improved care,
whereas the rest of the relative risk re-
duction of 49% in diabetic individuals
mayberelatedtootherchanges,suchas
earlier diagnosis of type 2 diabetes and
an increasing proportion of individuals
with a shorter duration of diabetes. Ad-
ditional effort is still required to reach
the goal of reducing amputations by
one-half.
Amputation rates in Finland began
falling 20 years ago. A 41% decrease
was reported for Southern Finland from
1984 to 2000 (15). The crude incidence
for any ﬁrst lower limb amputation
among individuals with diabetes in Fin-
land decreased from 924 to 387 per
100,000 from 1988 to 2002 (16). In our
data, the incidence of the ﬁrst major am-
putation has dropped signiﬁcantly, as in
many other reports (17,18), but even
faster declines have been reported (8–
11). In Tayside and Suffolk, faster
changes resulted from local multidisci-
plinaryactivities(8,9).InFinland,thefall
in the incidence can also be attributed to
improved care of cardiovascular risk fac-
tors (19) and better management of foot
problems, not forgetting the vascular and
plastic surgery treatment chains estab-
lished in most hospital districts between
1995and2000(20).Vascularsurgicalac-
tivityhasreducedtheincidenceofbelow-
knee amputations among individuals
with diabetes aged 66 years (21).
In our data, the majority of amputa-
tionswereperformedforindividualswith
diabetes, who had a more than sevenfold
relative risk compared with that for the
nondiabetic population. This ﬁnding is
similar to other reports (3,6). The highest
amputation rate was observed in the Y-
ITDM group. The relative risk was most
prominent among those aged 30–49
years, being 44.3 for men and 68.8 for
women. In England, a hospital-based
study found that the relative risk for ma-
jor amputations among diabetic individ-
uals was 36-fold (5). Our ﬁgures are also
in line with a Swedish study in which in-
dividuals with type 1 diabetes had an 86-
fold incidence of lower limb amputations
compared with that of the age-matched
general population (7).
In our study, the cumulative mortal-
ity after the ﬁrst major amputation was
high: for the 1st year it was between 27
and 57%, depending on the age-group.
Five-year mortality varied between 60
and 90%. Hambleton et al. (22) reported
a 5-year mortality of almost 90% after
above-kneeamputationand70%afterbe-
low-knee amputation, being signiﬁcantly
higher than that among age-matched dia-
betic control subjects without amputa-
tion.InManchester,U.K.,61%ofdiabetic
amputees aged 67–76 years had died
within 5.2 years, which was considered
similar to the percentage for the nondia-
betic group (23). In an analysis of a Finn-
ish hospital district, the survival among
diabetic amputees was worse than that
among nondiabetic amputees, although
diabetic individuals were younger (24).
Another study from the U.K. showed that
Figure 2—Cumulative 5-year mortality (percentage) after the ﬁrst major amputation among individuals with diabetes: A: men and women
according to age-groups 65 years, 65–75 years, and 75 years; B: in relation to the subgroup of diabetes; C: in relation to the amputation level
(below the knee or above the knee).
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tality than those without diabetes (25).
Low survival after amputation may
partlybeexplainedbytheaggressivelimb
salvage policy, in which amputations are
performed only when there is no option
forrevascularization.Thosewhoundergo
major amputations are typically patients
withlowlifeexpectancy.Nevertheless,ef-
forts should be made to offer optimal care
to diabetic amputees to avoid premature
mortality.
We also found some sex-related dif-
ferences. The reduction in the risk of am-
putation over time was greater among
women than among men, especially in
older age-groups. This can result from
differences in the prevalence of smoking.
We did not ﬁnd any other reports of sex
differencesinmortality(23).Obviously,a
major challenge is how to improve diag-
nosis, prevention, and foot care among
Finnish diabetic men to reduce their am-
putation rate and prolong their amputa-
tion-free years.
A major strength of our study was the
useofcomprehensivenationalregistersto
follow the development of diabetes and
amputation incidences for all treated dia-
beticindividualsinFinlandoveralengthy
time period. Other national studies have
used estimates of the prevalence of diabe-
tes to calculate the diabetic population
(18). In addition, we were able to com-
pare different groups of diabetic popula-
tions. Some methodological weaknesses
still exist. The groups in the analysis were
not identiﬁed from the medical diagnosis
of diabetes types but from medication
and hospital discharge registers. Those
individuals who were treated with diet
only were classiﬁed as nondiabetic indi-
viduals, if diabetes was not reported in
any of the registers used. The duration
of diabetes was approximated using the
time from the ﬁrst registration of diabe-
tes,whichinmostcaseswastheonsetof
treatment and not the ﬁrst signs of dia-
betes. Despite these weaknesses this
material is unique in the world. Our
data encompass the whole population
of a country; all diabetic individuals re-
ceiving medication have been identi-
ﬁed, and all amputations have been
registered since 1987 and analyzed over
an 11-year period according to sex and
diabetic groups.
Our analysis of a national database
detected an almost 50% reduction in the
standardized incidence of major amputa-
tions in individuals with diabetes aged
11 years. About half of this change was
due to the increasing size of the diabetic
population. The age-adjusted time from
the registration of diabetes to the ﬁrst ma-
joramputationincreasedby1.2yearsand
in a subgroup of young diabetic individ-
uals by 3.2 years. The risk for a major
amputation was more than sevenfold for
individuals with diabetes compared with
those without, and the 5-year mortality
after the ﬁrst major amputation was high.
In Finland, men with diabetes in particu-
lar are prone to limb loss, indicating a
challenge to the national diabetes pro-
gram in the future.
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